| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yu-Ning Her, Ya-Hsuan Wang, Shin-Chang Kuo, Chun-Yen Chen, Yi-Wei Ye. Repeated Pisa Syndrome Induced Successively by Risperidone, Olanzapine, and Quetiapine in a Female Patient With Dementia. American journal of therapeutics. vol 31. issue 6. 2025-01-10. PMID:39792504. |
repeated pisa syndrome induced successively by risperidone, olanzapine, and quetiapine in a female patient with dementia. |
2025-01-10 |
2025-01-13 |
Not clear |
| Melissa J Ankravs, Andrew Udy, Rinaldo Bellomo, Jeffrey J Presneill, Laura Adams, Yasmine Ali Abdelhamid, Michael Bailey, Jasmin Board, Kathleen Byrne, Glenn Eastwood, Maurice Le Guen, Emma-Leah Martin, Mark P Plummer, Megan Richardson, Lucy Sharrock, Meredith Young, Adam M Dean. Olanzapine versus quetiapine in critically ill patients with hyperactive delirium: Protocol for a multicentre, cluster-randomised, double-crossover, pragmatic clinical trial (CALM-ICU). Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. vol 26. issue 4. 2025-01-09. PMID:39781498. |
olanzapine versus quetiapine in critically ill patients with hyperactive delirium: protocol for a multicentre, cluster-randomised, double-crossover, pragmatic clinical trial (calm-icu). |
2025-01-09 |
2025-01-13 |
Not clear |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
the numbers of cases of nms (smq code: 20000044) reported for risperidone, aripiprazole, haloperidol, olanzapine, and quetiapine were 1691, 1294, 1132, 1056, and 986, respectively. |
2024-10-01 |
2024-10-03 |
Not clear |
| Qi He, Peixin Zhu, Xiyan Liu, Chunyue Hu. Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis. Schizophrenia research. vol 271. 2024-08-07. PMID:39111258. |
association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: a systematic review and meta-analysis. |
2024-08-07 |
2024-08-10 |
Not clear |
| Janusz Rybakowsk. Sixty years of recurrence prevention in mood disorders. Psychiatria polska. vol 58. issue 2. 2024-07-14. PMID:39003507. |
since the mid-1990s, 2nd generation of mood-stabilizing drugs has been introduced, including some atypical antipsychotics (clozapine, olanzapine, quetiapine, aripiprazole, risperidone) and anticonvulsant drug, lamotrigine, showing prophylactic activity in bipolar mood disorder. |
2024-07-14 |
2024-07-16 |
Not clear |
| Alejandro G Szmulewicz, Gonzalo Martínez-Alés, Roger Logan, Maria Ferrara, Christian Kelly, Diane Fredrikson, Juan Gago, Sarah Conderino, Covadonga M Díaz-Caneja, Joaquín Galvañ, Lorna Thorpe, Vinod Srihari, Lakshmi Yatham, Deepak K Sarpal, Ann K Shinn, Celso Arango, Dost Öngür, Miguel A Hernán, On Behalf Of The Fep-Causal Collaboratio. Antipsychotic drugs in first-episode psychosis: A target trial emulation in the FEP-CAUSAL Collaboration. American journal of epidemiology. 2024-04-05. PMID:38576166. |
the estimated 12-month risks of discontinuation for aripiprazole, first-generation agents, olanzapine, paliperidone, quetiapine, and risperidone (95% ci) were: 61.5% (52.5-70.6), 73.5% (60.5-84.9), 76.8% (67.2-85.3), 58.4% (40.4-77.4), 76.5% (62.1-88.5), and 74.4% (67.0-81.2) respectively. |
2024-04-05 |
2024-04-07 |
Not clear |
| Chunlei Gao, Tongpei Zhou, Sihan Liu, Chenyang Miao, Jingting Feng, Yifan Ding, Yanni L. Revealing receptor-ligand interactions of atypical antipsychotic drugs and screening anti-schizophrenia ingredients in Magnolia officinalis based on 5-HTR2A-SNAP-Tag/CMC and DRD2-SNAP-Tag/CMC models. Journal of chromatography. A. vol 1720. 2024-03-05. PMID:38442497. |
binding assays showed that the effects of three atypical antipsychotics (including clozapine, olanzapine, and quetiapine) on 5-htr2a were stronger than their effects on drd2. |
2024-03-05 |
2024-03-08 |
Not clear |
| Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszn. Direct Immersion-Solid Phase Microextraction for Therapeutic Drug Monitoring of Patients with Mood Disorders. Molecules (Basel, Switzerland). vol 29. issue 3. 2024-02-10. PMID:38338419. |
it has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. |
2024-02-10 |
2024-02-12 |
Not clear |
| Xue-Zhu Feng, Zhe Li, Zi-Yi Li, Ke Wang, Xuan Tan, Yu-Yu Zhao, Wei-Feng Mi, Wei-Li Zhu, Yan-Ping Bao, Lin Lu, Su-Xia L. Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis. Psychiatry research. vol 332. 2023-12-27. PMID:38150810. |
aripiprazole is the most effective treatment for bipolar mania [effect size = -0.90, 95% ci: -1.59, -0.21] and tourette's disorder [effect size = -0.80, 95% ci: -1.14, -0.45], olanzapine for bipolar depression [effect size = -0.86, 95% ci: -1.32, -0.39] and post-traumatic stress disorder [effect size = -0.98, 95% ci: -1.55, -0.41], lurasidone for depression [effect size = -0.66, 95% ci: -0.82, -0.50], quetiapine for anxiety [effect size = -1.20, 95% ci: -1.96, -0.43], sleep disorders [effect size = -1.2, 95% ci: -1.97, -0.58], and delirium [effect size = -0.36, 95% ci: -0.70, -0.03], and risperidone for obsessive-compulsive disorder [effect size = -2.37, 95% ci: -3.25, -1.49], respectively. |
2023-12-27 |
2023-12-30 |
Not clear |
| Jolanta Jaśkowska, Anna Karolina Drabczyk, Damian Kułaga, Przemysław Zaręba, Zbigniew Majka, Przemysław Jodłowsk. A new synthetic ultrasound-assisted method for dibenzoepines. Heliyon. vol 9. issue 7. 2023-08-04. PMID:37539205. |
in this study, we have developed a new ultrasonic synthesis method of dibenzoepines using olanzapine and quetiapine, which are well-known drugs for the treatment of schizophrenia and bipolar disorder. |
2023-08-04 |
2023-08-14 |
Not clear |
| Sanja Strbe, Ivan Maria Smoday, Ivan Krezic, Luka Kalogjera, Vlasta Vukovic, Helena Zizek, Slaven Gojkovic, Hrvoje Vranes, Ivan Barisic, Suncana Sikiric, Marijan Tepes, Katarina Oroz, Filip Brkic, Martin Drinkovic, Lidija Beketic Oreskovic, Jelena Popic, Alenka Boban Blagaic, Anita Skrtic, Mario Staresinic, Sven Seiwerth, Predrag Sikiri. Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy. Pharmaceuticals (Basel, Switzerland). vol 16. issue 6. 2023-06-28. PMID:37375736. |
in rats with complete calvariectomy, medication (bpc 157 10 µg/kg, 10 ng/kg ip or ig) was given 5 min after distinctive dopamine agents (mg/kg ip) (haloperidol (5), fluphenazine (5), clozapine (10), risperidone (5), olanzapine (10), quetiapine (10), or aripiprazole (10), domperidone (25), amphetamine (10), and combined amphetamine and haloperidol) and assessed at 15 min thereafter. |
2023-06-28 |
2023-08-14 |
rat |
| Stefan Leucht, Johannes Schneider-Thoma, Angelika Burschinski, Natalie Peter, Dongfang Wang, Shimeng Dong, Maximilian Huhn, Adriani Nikolakopoulou, Georgia Salanti, John M Davi. Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 22. issue 2. 2023-05-10. PMID:37159349. |
in terms of overall symptoms, olanzapine was on average more efficacious than ziprasidone (standardized mean difference, smd=0.37, 95% ci: 0.26-0.49), asenapine (smd=0.33, 95% ci: 0.21-0.45), iloperidone (smd=0.32, 95% ci: 0.15-0.49), paliperidone (smd=0.28, 95% ci: 0.11-0.44), haloperidol (smd=0.27, 95% ci: 0.14-0.39), quetiapine (smd=0.25, 95% ci: 0.12-0.38), aripiprazole (smd=0.16, 95% ci: 0.04-0.28) and risperidone (smd=0.12, 95% ci: 0.03-0.21). |
2023-05-10 |
2023-08-14 |
human |
| Janusz K Rybakowsk. Application of Antipsychotic Drugs in Mood Disorders. Brain sciences. vol 13. issue 3. 2023-03-29. PMID:36979224. |
the second-generation, so-called atypical antipsychotics (sgas), such as clozapine, risperidone, olanzapine, and quetiapine, have antimanic activity and are also effective for the maintenance treatment of bipolar disorder. |
2023-03-29 |
2023-08-14 |
human |
| Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Bo-Hyun Yoon, Jung Goo Lee, Won Kim, InKi Sohn, Sung-Yong Park, Se-Hoon Shim, Jeong Seok Seo, Il Han Choo, Chan-Mo Yang, Myung Hun Jung, Duk-In Jon, Moon-Doo Ki. Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 21. issue 1. 2023-01-26. PMID:36700310. |
aripiprazole, quetiapine and olanzapine were the first-line aaps for nearly all phases of bipolar disorder across guidelines. |
2023-01-26 |
2023-08-14 |
Not clear |
| Malgorzata Zaremba, Pawel Serafin, Patrycja Kleczkowsk. Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis. Biomedicines. vol 11. issue 1. 2023-01-21. PMID:36672631. |
atypical neuroleptics (i.e., olanzapine, risperidone, quetiapine) and typical haloperidol have been used in symptomatic treatment due to their efficacy, especially in positive symptoms (hallucinations and delusions). |
2023-01-21 |
2023-08-14 |
Not clear |
| Gudrun Hefner, Jan Wolff, Sermin Toto, Pamela Reißner, Ansgar Klimk. Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry. Journal of neural transmission (Vienna, Austria : 1996). 2022-09-07. PMID:36070009. |
the most often off-label prescribed drugs were quetiapine and mirtazapine for organic mental disorders (f0/g3), valproate and quetiapine in patients with disorders due to psychoactive substance use (f1), valproate in patients with psychotic disorders (f2), and risperidone and olanzapine in patients with affective disorders (f3). |
2022-09-07 |
2023-08-14 |
Not clear |
| Scandashree Sanman, Padmaja Udaykumar, Aruna Yadiya. Association between Sexual dysfunction and dose of atypical antipsychotics: essential to learn the basics. Journal of clinical pharmacology. 2022-08-08. PMID:35939487. |
sd was more frequent with risperidone (48.5%) than olanzapine (28.4%), quetiapine (0%). |
2022-08-08 |
2023-08-14 |
human |
| Scandashree Sanman, Padmaja Udaykumar, Aruna Yadiya. Association between Sexual dysfunction and dose of atypical antipsychotics: essential to learn the basics. Journal of clinical pharmacology. 2022-08-08. PMID:35939487. |
olanzapine has a better safety profile in terms of sd, experience with quetiapine is insufficient. |
2022-08-08 |
2023-08-14 |
human |
| Meng He, Jun Fan, Ruqin Zhou, Guanbin Gao, Ruoxi Li, YuFeng Zuo, Benben Li, Yanmei Li, Taolei Su. NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist. Frontiers in aging neuroscience. vol 14. 2022-05-26. PMID:35615587. |
twenty-four hour treatment with olanzapine, quetiapine, risperidone, or haloperidol dose-dependently increased the protein expression of astrocytic nlrp3, nlrp6, caspase-1, caspase-4, and gsdmd. |
2022-05-26 |
2023-08-13 |
Not clear |
| Meng He, Jun Fan, Ruqin Zhou, Guanbin Gao, Ruoxi Li, YuFeng Zuo, Benben Li, Yanmei Li, Taolei Su. NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist. Frontiers in aging neuroscience. vol 14. 2022-05-26. PMID:35615587. |
co-treatment with a histamine h1 receptor agonist, 2-(3-trifluoromethylphenyl) histamine (fmph), dose-dependently reduced the increased expression of nlrp3, caspase-1 and gsdmd induced by olanzapine, quetiapine, risperidone, or haloperidol. |
2022-05-26 |
2023-08-13 |
Not clear |